『HealthTech Invest』のカバーアート

HealthTech Invest

HealthTech Invest

著者： Tom Kluz
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

 The HealthTech Invest podcast will help you be in the know on all things Healthcare Investing. Through interviews with cutting-edge health entrepreneurs, savvy investors, health system leaders, and more, the HealthTech Invest podcast powered by Niterra, will help you level up and make an impact in healthcare investing.Copyright Health Tech Invest 衛生・健康的な生活
エピソード
  • The Spreadsheet Trap: Why Growth Equity Fails Without Operator Rigor with Joe Kaiser, CEO and Managing Director at Mercato Partners

    The Spreadsheet Trap: Why Growth Equity Fails Without Operator Rigor with Joe Kaiser, CEO and Managing Director at Mercato Partners
    2026/02/19
    Real growth investing creates durable outcomes when disciplined capital allocation is matched with operator-level rigor and clear value creation. In this episode, Joe Kaiser, CEO and Managing Director at Mercato Partners, shares how his experience at Blackstone and in operating roles, including scaling Vivint Solar from zero to $200M in revenue through an IPO and a $5B exit, shaped his “show me” mindset, quantitative rigor, and focus on unit economics. He explains Mercato’s heartland thesis, how geography affects founder incentives, talent development, and board dynamics, and what coastal investors often misunderstand about scaling outside major hubs. Joe outlines Mercato’s “head in, hands out” board approach, when engagement is most critical in balance sheet decisions, and why respectful, direct communication matters. He also critiques growth equity overcapitalization, warns against spreadsheet-driven projections, and shares views on AI, deep tech diligence, hardware-enabled moats, and hiring leaders who’ve done it before. Tune in and learn how to build and fund enduring companies without chasing hype or relocating to the coast. Resources: Connect with and follow Joe Kaiser on LinkedIn. Follow Mercato Partners on LinkedIn and explore their website. Watch the interview here.
    続きを読む 一部表示
    41 分
  • How AI Can Earn Trust Without Becoming A Black Box with Ken Fine, CEO of Affinity

    How AI Can Earn Trust Without Becoming A Black Box with Ken Fine, CEO of Affinity
    2026/02/03
    Strong decision-making systems are built when data quality, human behavior, and trust are treated as inseparable. In this episode, Ken Fine, CEO of Affinity, shares how his career path from naval engineering and physics to enterprise SaaS leadership shaped his thinking about data, systems, and decision-making. He reflects on designing high-stakes systems in the Navy, applying behavioral economics at Financial Engines, and learning how to separate signal from noise at Medallia. Ken explains why differentiated data matters more than algorithms alone, how speed and accuracy work together to build trust, and why transparency is essential as AI becomes more embedded in workflows. He also discusses leadership, emphasizing accountability balanced with empathy, and introduces his “nail it, then scale it” framework for building sustainable companies. Tune in and learn how data, trust, and human judgment come together to power better decisions at scale.Resources: Connect with and follow Ken Fine on LinkedIn. Follow Affinity.co on LinkedIn and explore their website.
    続きを読む 一部表示
    49 分
  • Electricity as Medicine: Inside the Future of Personalized Tremor Therapy with Deanna Harshbarger, CEO of Cala Health

    Electricity as Medicine: Inside the Future of Personalized Tremor Therapy with Deanna Harshbarger, CEO of Cala Health
    2025/12/04
    What if treating tremor meant personalizing therapy to your exact physiology, every single day? In this episode, Deanna Harshbarger, CEO of Cala Health, discusses how precision neuromodulation is transforming care by measuring each patient’s unique tremor and tailoring therapy in real-time. She explains why millions of essential tremor and Parkinson’s patients are left undertreated under today’s pharma-first, procedure-heavy system. She shares how Cala’s wearable, watch-like device restores daily function and dignity without habituation or invasive surgery. She also explains why modernizing reimbursement, regulation, and clinical workflows is crucial for digital therapeutics to scale. Tune in to discover how electricity is becoming medicine. Resources: Connect with and follow Deanna Harshbarger on LinkedIn. Follow Cala Health on LinkedIn and explore their website.
    続きを読む 一部表示
    59 分
まだレビューはありません